Nice RNS to try and keep Shareholders sweet but the Elephant in the Room is the other ‘G’ word.
Deafening silence regarding a timeline for restarting operations. That is what the market is interested in, not Gilar. Every passing week makes a fundraising more likely.
Good morning Tricky, I think we’ve had a persistent seller for a while now which I think has been backed up by a bit of short selling. These guys know how far to push it though and we are getting very close to a critical support level at around the 30/31p mark. That represents the 20DMA. We wouldn’t want to drop through that but I suspect we will see very strong support at that level (if it gets that low)
All very short term shenanigans imo. Stocks that have shot up v quickly in a short space of time are vulnerable to some short selling but it’s a dangerous game for them to play because this company is potentially full of more good news!
Keep the faith All
Fintech - agreed all of your milestones before year end.
Plus confirmation of ‘cancelled’ licences now reissued.
We might also get something about a renewed drilling/exploration programme for 2024.
I think the biggie is formal confirmation announcement of JV/Offtake and Project Funding with LB Group. Don’t forget this is not yet in the bag so the market will discount it until it is. Once it is confirmed the overall project is hugely derisked.
I’ve got a feeling we’re going to find out quite soon what kind of partnerships they’ve put together but they certainly appear to be the right ones - producing tests at scale.
I’m very happy that they are clearly moving at pace commercially. They fully appreciate that is the focus now.
I’m confident there will be a good reasonably regular newsflow. Two reasons. The first is that there is actually going to be a lot of activity in the next several months. But the second, and equally importantly, is that Greg Martyr is a good switched on communicator who realises the importance of engaging with shareholders. The same could not be said for the previous incumbent.
Certainly exciting times ahead.
Newuncle- no worries mate we’re all here to make money. Fwiw agree with your last post.
Not bothered about current SP action. Longer term view. It’s all supply and demand. I think there are signs this is bottoming out now and consolidating nicely for our next push up. :)
Applebee- that’s precisely what this is. Forward selling for a fundraising. I would hope at no less than 4p.
I don’t know why anybody hadn’t realised!
No matter. They need the cash now to push on. That is entirely reasonable. Money doesn’t grow on trees!
If you think about it logically many are under the amount you would pay for commission on such a ‘trade’. Just think of it as MM book keeping which has no consequence other than disclosing the current bid or ask price. 😊👍🏻
We are onto something here Boys and Girls. This is the REAL DEAL. Finally I’ve found it.
Do NOT worry about day to day SP machinations.
It really does not matter a jot.
A £68m valuation for the mega lucrative opportunity which has opened up for the Episwitch PSE test? Don’t make me laugh.
This is the first time I have held a share which I believe offers the best chance of becoming a millionaire. Possibly even a multi millionaire. You think this is hyperbole? Ramping?
Well before you make such comments go away and research this thoroughly. Then do it again.
Until you realise I am correct.
Quote: “Currently, metastatic prostate cancer is associated with substantial annual healthcare costs, which have increased over time as new oral therapies for the treatment of metastatic prostate cancer have been approved. USA population-level incidence of metastatic prostate cancer decreased after prostate cancer screening with PSA testing was widely adopted.
Future generations will be among the first to witness more affordable, accessible, and diagnostic-associated treatment approaches for prostate cancer as the incidence of the disease increases in the future. In an attempt to address the challenges faced by prostate cancer research organizations & societies, governments are investing in numerous initiatives that are meant to raise awareness about the disease, thereby assisting them in developing effective medications.”
So first observation : ‘ USA population-level incidence of metastatic prostate cancer decreased after prostate cancer screening with PSA testing was widely adopted.’
- Yes imagine the impact PSE will have then if the relatively ineffective PSA had an effect.
Second observation: ‘ Future generations will be among the first to witness more affordable, accessible, and diagnostic-associated treatment approaches for prostate cancer’
- Not future generations, THIS generation. Now! Because of the cost saving impact of PSE.
I think some punters who do not have a long term horizon (bought in the 2’s, 3’s and 4’s ) here but were hanging on to see what happens have been spooked.
A lot have predictably jettisoned - were only here for the licence outcome. The 20th Oct deadline was well known.
I’m not going to say this is what I expected but this is AIM and it is a crazy irrational market at times. Sensible ‘stickier’ longer term investors will be (I hope) waiting on the sidelines for this irrational behaviour to die down. Then start to buy.
PaulFG talked about ‘hot money’ last week and there has been some hot money here. We have to let that run its course.
The fundamentals are absolutely mouth watering here but short term traders don’t give a fig.
Fortunately for me I have an exceptionally low average (it couldn’t be any lower lol) so I’m sitting pretty, but some are trying to protect much smaller profits.
I’m going to sit tight, watch it all unfold, and I am supremely confident of a much higher SP within weeks.